Amplion Announces New Biomarker Usage Feature

Anyone involved in biomarkers knows how imperative it is to stay informed about biomarker developments. Here at Amplion, we aggregate and annotate cutting edge biomarker information and publish it in BiomarkerBase, so you can stay up to date on the clinical biomarker...

Chart of the Week: Celgene Poised to Dominate Personalized Medicine?

In our Charts of the Week over the last several weeks we have been analyzing the use of unique biomarkers by pharmaceutical companies.  We are extending that analysis today with a look at the biomarker discovery activity of pharma companies as compared with the number...

Unique Biomarkers Are Associated With More Drug Approvals

In our Chart of the Week post from last week we presented an analysis of the number of unique biomarkers being used by leading drug developers in their clinical trials (unique biomarkers being defined as those that aren’t being used by any other companies). This...

Real-Time COVID R&D Tracking

As COVID-19 infections continue to spread, organizations with technologies or devices that can support new drug, vaccine, or test development have a life-saving contribution to make. The Amplion Intelligence Platform can alert you to new COVID-19 trial activities in real-time and automatically match you to partners who need your unique capabilities immediately. It’s already tomorrow somewhere, so let us help you start today.  Learn More

Request Access